Breaking News

Beigene Ltd (B1ME34)

Symbol	Exchange	Currency
B1ME34	B3	BRL	Delayed
ONC	NASDAQ	USD	Real-time
688235	Shanghai	CNY	Delayed
6160	Hong Kong	HKD	Delayed

Add to/Remove from a Portfolio Add to Watchlist

61.50 0.00 0.00%

16/07 - Closed. Currency in BRL

Type: Equity

Market: Brazil

ISIN: BRB1MEBDR009

Volume: 0
Bid/Ask: 51.00 / 62.34
Day's Range: 61.50 - 61.50

General
Chart
- Streaming charts
- Interactive Chart
News & Analysis
- News
- Analysis & Comment
Financials
Technical
Forum

Beigene Ltd Company Profile

Get an in-depth profile of Beigene Ltd, including a general overview of the company's business and key management, as well as employee data and location and contact information.

IndustryBiotechnology & Medical Research

SectorHealthcare

Employees

11000

Equity Type

DRC

BeOne Medicines Ltd., an oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally. The company’s commercial stage products include BRUKINSA, a small molecule inhibitor of Bruton’s Tyrosine Kinase (BTK) for the treatment of various blood cancers; TEVIMBRA, an anti-PD-1 antibody immunotherapy for the treatment of various solid tumor and blood cancers; and PARTRUVIX, a selective small molecule inhibitor of PARP1 and PARP2 enzymes that is being evaluated as a monotherapy and in combinations for the treatment of various solid tumors. Its clinical stage products comprise Sonrotoclax BGB-11417, a small molecule Bcl-2 inhibitor; BGB-16673, a BTK-targeting chimeric degradation activation compound active against wild-type and mutant BTK; Ociperlimab (BGB-A1217), a TIGIT inhibitor; BG-60366, an EGFR-targeted CDAC; BG-89894 (SYH2039), a MAT2A Inhibitor; BGB-58067, an MTA-Cooperative PRMT5 Inhibitor; BG-T187, an anti-EGFRxMET trispecific antibody; BGB-26808, a HPK-1 Inhibitor; BGB-C354, an anti-B7H3 ADC; Zanidatamab, a bispecific HER2-targeted antibody; BG-C137, an anti-FGFR2b ADC; BGB-53038, a Pan-KRAS Inhibitor; BGB-B2033, an anti-GPC3x4-1BB bispecific antibody; BGB-B3227, an anti-MUC1xCD16A bispecific antibody; BG-C477, an anti-CEAADC; BGB-43395, a CDK4 Inhibitor; BG-68501, a CDK2 Inhibitor; BG-C9074, an anti-B7H4 ADC; BGB-21447, a Bcl-2 Inhibitor; and BGB-45035, an IRAK4-targeted CDAC. It also has various preclinical programs. The company has agreements Amgen, BMS, Bio-Thera, EUSA Pharma, Luye Pharmaceutical, and Novartis. The company was formerly known as BeiGene, Ltd. and changed its name to BeOne Medicines Ltd. in May 2025. BeOne Medicines Ltd. was incorporated in 2010 and is based in Basel, Switzerland.

Contact Information

Address Aeschengraben 27 21st Floor
Basel, 4051
Switzerland

Phone 41 61 685 19 00

Fax -

Web beonemedicines.com

Top Executives

Name	Age	Since	Title
Michael Qingqing Yi	-	-	Independent Non-Executive Director & Co-Chairman Advisory Committe
Xiaodong Wang	62	2010	Co-Chairman of Scientific Advisory Board, Non-Executive Director & Co-Founder
Ranjeev Krishana	51	2014	Member of Commercial & Medical Affairs Advisory Committee and Independent Lead Director
John V. Oyler	57	2010	Co-Founder, Executive Chairman & CEO
Anthony C. Hooper	70	2020	Chairman of Commercial & Medical Affairs Advisory Committee and Ind. Non Executive Director
Shalini Sharp	50	2024	Independent Non-Executive Director
Margaret Han Dugan	68	2022	Member of SA, Commercial & Medical Affairs Advisory Committee and Independent Non-Exec. Director
Alessandro Riva	65	2022	Co-Chairman of Scientific Advisory Committee & Independent Non-Executive Director
David P. Schenkein	68	2025	Member of Scientific Advisory Board
Charles L. Sawyers	66	2025	Member of Scientific Advisory Board
Neal Rosen	75	2025	Member of Scientific Advisory Board
Michael J. Goller	50	2015	Independent Non-Executive Director & Member of the Scientific Advisory Committee
Corazon Dating Sanders	68	2020	Independent Non-Executive Director and Member of Commercial & Medical Affairs Advis. & SA Committee
Olivier Brandicourt	69	2024	Independent Non-Executive Director & Commercial and Medical Affairs Advisory Committee
Qingqing Yi	53	2014	Independent Non-Executive Director and Member of Scientific Advisory Committee

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:

Enrich the conversation
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically.
Use standard writing style. Include punctuation and upper and lower cases.
NOTE: Spam and/or promotional messages and links within a comment will be removed
Avoid profanity, slander or personal attacks directed at an author or another user.
Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I have read and understood Investing.com Nigeria's comment guidelines and agree to the terms described.

I Agree

B1ME34 Comments

Write your thoughts about Beigene Ltd

Are you sure you want to delete this chart?

Delete Cancel

Post

Post also to:

Replace the attached chart with a new chart ?

Replace Cancel

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.

<div id="comment">
				<div class="comment js-comment" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="">
    <div class="mainComment js-content">
       <div class="commentInnerWrapper">
        <a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody">
                					<span class="commentUsername">
                    	<a href="{userLink}" class="js-user-link js-user-name">{username}</a>
					</span>
                                <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
                <div class="commentDropDown js-commentDropDownWrapper " data-user-id="" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

<div class="js-option addRow follow">
            <div class="js-follow-post-button" data-reg_ep="follow comment">
                <span class="alertfollowIcon middle"></span>Follow this post            </div>
            <div class="js-unfollow-post-button displayNoneImp">
                <span class="alertUnfollowIcon middle"></span>Unfollow this post            </div>
        </div>

<div class="addRow js-option save"  data-reg_ep="save comment">
		<a href="javascript:void(0);" class="js-save-item-btn" data-item-type="comments" data-item-id="{commentID}">
			<i class="saveItemBigIcon middle"></i>
			Save		</a>
	</div>
	<div class="addRow saveItemsConfirmation noHover displayNone js-saveItemResult">
		
<div class="content js-saveItemSuccess displayNone">
	<span class="mediumGreenSuccessIcon"></span><span>Saved. See <a href="/members-admin/saved-items" target="_blank">Saved Items</a>.</span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
<div class="content js-saveItemAlreadySaved saveItemAlreadySaved displayNoneImp">
	<span>This comment has already been saved in your <a href="/members-admin/saved-items" target="_blank">Saved Items</a></span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
	</div>

<div class="addRow shareButtons js-sharePopup displayNone">
			<div class="js-shareComment"><span class="js-shareCommentSpan"></span></div>
		</div>
	</div>
</div>
                 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div>             </div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="commentBigChart js-comment-chart" onclick="openViewChartPopup('{commentID}')">
					<img src="https://d72-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

<div class="reportComment js-flag float_lang_base_2">
                            <a href="javascript:void(0);" id="commentFlag_{commentID}">
                                <span class="reportCommentIcon middle"></span><span class="inlineblock middle">Report</span>
                            </a>
                        </div>
                    				</div>
					</div>
	   </div>
	</div>
	</div>			</div>
			<div id="reply">
				
    <div class="commentReply js-comment js-comment-reply" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="">
		<div class="commentInnerWrapper"><a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody js-content">
            				<span class="commentUsername">
					<a href="{userLink}" class="commentUsername js-user-link js-user-name" onMouseOver="">{username}</a>
				</span>
                        <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
			 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div> 			<div class="commentDropDown js-commentDropDownWrapper " data-user-id="" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

</div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="replyBigChart displayNone js-comment-chart">
					<img src="https://d72-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
				<span id="commentSmallChart{commentID}" class="commentSmallChart pointer js-comment-chart" onclick="openViewChartPopup('{commentID}')">
                    <img src="https://d72-invdn-com.investing.com/comments_images/{commentImageSmall}" width="116" height="52" alt="{commentAlt}">
                    <span class="chartMagnifyOverlay displayNone"></span>
                    <span class="searchGlassIcon chartMagnify displayNone"></span>
                </span>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

Are you sure you want to delete this chart?

Delete Cancel

Post

Replace the attached chart with a new chart ?

Replace Cancel

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

I feel that this comment is:

Spam

Offensive

Thank You!

Your report has been sent to our moderators for review

More Categories

1D1W1M6M1Y5YMax

NSE 30	4,935.73	+3.34	+0.07%
NSE All Share	134,599.33	+146.40	+0.11%
US 30	44,978.0	+76.1	+0.17%
US 500	6,406.8	+18.2	+0.28%
FTSE 100	9,127.65	+7.34	+0.08%
DAX	24,299.34	+66.26	+0.27%
South Africa Top 40	91,516.92	+213.52	+0.23%

Brent Oil	68.27	+0.61	+0.90%
Crude Oil WTI	65.77	+0.61	+0.94%
Gold	3,395.10	+2.60	+0.08%
Silver	38.308	-0.058	-0.15%
Copper	5.7848	-0.0002	0.00%
London Cocoa	5,485.00	+142.00	+2.66%
London Wheat	177.45	-0.25	-0.14%

Nigeria 10Y	15.954	0.000	0.00%
Nigeria 2Y	16.755	+0.000	+0.00%
U.K. 10Y	4.6150	-0.0170	-0.37%
Germany 10Y	2.6860	-0.0310	-1.14%
U.S. 10Y	4.373	-0.013	-0.30%
U.S. 5Y	3.941	-0.011	-0.28%
U.S. 2Y	3.911	-0.006	-0.15%

Fidelitybk	21.050	-0.150	-0.71%
Zenith Bank	74.90	+0.90	+1.22%
UBA	47.00	0.00	0.00%
First HoldCo	35.95	-0.25	-0.69%
Guaranty Trust Holding	94.30	+0.30	+0.32%
Sterling Bank	6.720	+0.120	+1.82%
Dangote Cement	506.00	+13.00	+2.64%

Recent Quotes

Name	Price	Chg.	Chg. %
B1ME34	61.50	0.00	0.00%
Aberdeen Global .	91.099	-0.601	-0.66%
300901	16.75	+0.27	+1.64%
294140	4,130	-35	-0.84%
PCIN	14,680.00	+51.00	+0.35%
Lähitapiola Kehit.	15.483	+0.130	+0.83%
UBS MSCI ACWI SF .	2,669.84	0.00	0.00%
9404	3,243.0	-68.0	-2.05%

Market Movers

Name	Last	Chg. %	Vol.
Access Holdings	28.20	+1.81%	5.34M
Oando Plc	62.60	+4.25%	2.45M
Zenith Bank	75.00	+1.35%	1.47M
Geregu Power	1,027.40	-10.00%	1.00M
BUA Cement	128.00	-5.19%	863.94K
Okomu Oil Palm	1,025.00	+2.71%	459.89K
Dangote Cement	502.10	+1.85%	387.86K

Name	Last	Chg. %	Vol.
Airtel Africa	2,541.50	+10.00%	0.00K
Champion Brew	13.55	+9.98%	2.23M
Guinness Nigeria	117.05	+9.96%	27.94K
Daarcomm	0.89	+9.88%	1.52M
Redstarex	13.62	+9.66%	48.36K
Sovereign Trust Insurance Plc	1.72	+9.55%	4.96M
Etranz	9.000	-4.76%	144.64K

Name	Last	Chg. %	Vol.
Geregu Power	1,027.40	-10.00%	1.00M
Total Nig	634.50	-10.00%	6.43K
Transcorp Power	288.00	-10.00%	75.82K
Abbey Mortgage Bank	7.20	-10.00%	40.73K
Conoil	211.10	-9.98%	5.83K
Juli	8.40	-9.68%	10.68K
Eunisell Interlinked	18.900	+5.59%	15.95K